2025-02-27 |
2025-02-25 |
V
Verkauf
|
AHMED NADIM
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
12.529
-2.8%
8,53
106.872 USD
|
12.529
-2.8%
|
8,53
|
106.872 USD
|
|
2025-02-27 |
2025-02-25 |
V
Verkauf
|
Jones Jeffrey Alan
Chief Medical Officer
Führungsperson
|
4.895
-2.7%
8,53
41.754 USD
|
4.895
-2.7%
|
8,53
|
41.754 USD
|
|
2025-02-27 |
2025-02-25 |
V
Verkauf
|
SUMER JACQUELYN L
Chief Legal Officer
Führungsperson
|
3.756
-2.7%
8,53
32.039 USD
|
3.756
-2.7%
|
8,53
|
32.039 USD
|
|
2025-02-27 |
2025-02-25 |
V
Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
3.756
-2.6%
8,53
32.039 USD
|
3.756
-2.6%
|
8,53
|
32.039 USD
|
|
2025-01-07 |
2025-01-06 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
4.000
-4.0%
12,51
50.040 USD
|
4.000
-4.0%
|
12,51
|
50.040 USD
|
|
2024-12-27 |
2024-12-24 |
V
Verkauf
|
AHMED NADIM
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
8.400
-3.1%
11,87
99.708 USD
|
8.400
-3.1%
|
11,87
|
99.708 USD
|
|
2024-12-20 |
2024-12-18 |
V
Verkauf
|
SUMER JACQUELYN L
Chief Legal Officer
Führungsperson
|
3.482
-3.7%
11,41
39.730 USD
|
3.482
-3.7%
|
11,41
|
39.730 USD
|
|
2024-12-20 |
2024-12-18 |
V
Verkauf
|
Jones Jeffrey Alan
Chief Medical Officer
Führungsperson
|
4.632
-3.9%
11,41
52.851 USD
|
4.632
-3.9%
|
11,41
|
52.851 USD
|
|
2024-12-20 |
2024-12-18 |
V
Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
4.693
-4.5%
11,41
53.547 USD
|
4.693
-4.5%
|
11,41
|
53.547 USD
|
|
2024-12-16 |
2024-12-12 |
V
Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
3.489
-3.2%
12,52
43.682 USD
|
3.489
-3.2%
|
12,52
|
43.682 USD
|
|
2024-11-07 |
2024-11-05 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
8.000
-6.9%
15,64
125.120 USD
|
8.000
-6.9%
|
15,64
|
125.120 USD
|
|
2024-09-09 |
2024-09-05 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
8.000
-6.5%
18,09
144.720 USD
|
8.000
-6.5%
|
18,09
|
144.720 USD
|
|
2024-07-09 |
2024-07-05 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
8.000
-6.1%
16,33
130.640 USD
|
8.000
-6.1%
|
16,33
|
130.640 USD
|
|
2024-05-08 |
2024-05-07 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
5.606
-4.1%
30,06
168.516 USD
|
5.606
-4.1%
|
30,06
|
168.516 USD
|
|
2024-05-08 |
2024-05-06 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
20.277
-13.5%
28,54
578.706 USD
|
20.277
-13.5%
|
28,54
|
578.706 USD
|
|
2024-05-08 |
2024-05-06 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
37.723
-20.1%
27,82
1.049.454 USD
|
37.723
-20.1%
|
27,82
|
1.049.454 USD
|
|
2024-02-02 |
2024-02-01 |
GV
Geplanter Verkauf
|
Savill Corrine
Chief Business Officer
Führungsperson
|
40.000
-19.4%
16,18
647.200 USD
|
40.000
-19.4%
|
16,18
|
647.200 USD
|
|
2024-01-30 |
2024-01-29 |
GV
Geplanter Verkauf
|
Savill Corrine
Chief Business Officer
Führungsperson
|
40.000
-19.4%
14,09
563.600 USD
|
40.000
-19.4%
|
14,09
|
563.600 USD
|
|
2024-01-24 |
2024-01-23 |
GV
Geplanter Verkauf
|
Savill Corrine
Chief Business Officer
Führungsperson
|
21.316
-11.4%
12,46
265.597 USD
|
21.316
-11.4%
|
12,46
|
265.597 USD
|
|
2024-01-24 |
2024-01-22 |
GV
Geplanter Verkauf
|
Savill Corrine
Chief Business Officer
Führungsperson
|
4.125
-2.4%
12,02
49.583 USD
|
4.125
-2.4%
|
12,02
|
49.583 USD
|
|
2024-01-24 |
2024-01-22 |
GV
Geplanter Verkauf
|
Savill Corrine
Chief Business Officer
Führungsperson
|
14.559
-7.9%
12,18
177.329 USD
|
14.559
-7.9%
|
12,18
|
177.329 USD
|
|
2023-12-27 |
2023-12-26 |
V
Verkauf
|
AHMED NADIM
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
4.272
-3.7%
9,24
39.473 USD
|
4.272
-3.7%
|
9,24
|
39.473 USD
|
|
2023-12-22 |
2023-12-21 |
V
Verkauf
|
Jones Jeffrey Alan
Chief Medical Officer
Führungsperson
|
1.860
-3.2%
8,50
15.810 USD
|
1.860
-3.2%
|
8,50
|
15.810 USD
|
|
2023-12-22 |
2023-12-21 |
V
Verkauf
|
Trigilio Jeffrey
Chief Financial Officer
Führungsperson
|
1.920
-2.2%
8,50
16.320 USD
|
1.920
-2.2%
|
8,50
|
16.320 USD
|
|
2023-12-22 |
2023-12-21 |
V
Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
1.145
-1.3%
8,50
9.733 USD
|
1.145
-1.3%
|
8,50
|
9.733 USD
|
|
2023-12-22 |
2023-12-21 |
V
Verkauf
|
SUMER JACQUELYN L
Chief Legal Officer
Führungsperson
|
1.400
-3.1%
8,50
11.900 USD
|
1.400
-3.1%
|
8,50
|
11.900 USD
|
|
2023-12-20 |
2023-12-18 |
V
Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
238
-0.3%
8,22
1.956 USD
|
238
-0.3%
|
8,22
|
1.956 USD
|
|
2023-12-20 |
2023-12-18 |
V
Verkauf
|
Jones Jeffrey Alan
Chief Medical Officer
Führungsperson
|
386
-0.7%
8,22
3.173 USD
|
386
-0.7%
|
8,22
|
3.173 USD
|
|
2023-12-20 |
2023-12-18 |
V
Verkauf
|
Trigilio Jeffrey
Chief Financial Officer
Führungsperson
|
398
-0.5%
8,22
3.272 USD
|
398
-0.5%
|
8,22
|
3.272 USD
|
|
2023-12-20 |
2023-12-18 |
V
Verkauf
|
SUMER JACQUELYN L
Chief Legal Officer
Führungsperson
|
290
-0.6%
8,22
2.384 USD
|
290
-0.6%
|
8,22
|
2.384 USD
|
|
2023-12-13 |
2023-12-12 |
V
Verkauf
|
Michaelson Jennifer
Chief Scientific Officer
Führungsperson
|
1.068
-1.2%
7,81
8.341 USD
|
1.068
-1.2%
|
7,81
|
8.341 USD
|
|
2023-12-13 |
2023-12-12 |
V
Verkauf
|
Trigilio Jeffrey
Chief Financial Officer
Führungsperson
|
1.926
-2.2%
7,81
15.042 USD
|
1.926
-2.2%
|
7,81
|
15.042 USD
|
|
2023-06-29 |
2023-06-28 |
V
Verkauf
|
AHMED NADIM
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
759
-0.7%
11,40
8.653 USD
|
759
-0.7%
|
11,40
|
8.653 USD
|
|
2023-06-21 |
2023-06-20 |
V
Verkauf
|
Trigilio Jeffrey
Chief Financial Officer
Führungsperson
|
399
-0.5%
12,94
5.163 USD
|
399
-0.5%
|
12,94
|
5.163 USD
|
|
2023-06-21 |
2023-06-20 |
V
Verkauf
|
SUMER JACQUELYN L
Chief Legal Officer
Führungsperson
|
291
-0.6%
12,94
3.766 USD
|
291
-0.6%
|
12,94
|
3.766 USD
|
|
2023-06-21 |
2023-06-20 |
V
Verkauf
|
Jones Jeffrey Alan
Chief Medical Officer
Führungsperson
|
387
-0.7%
12,94
5.008 USD
|
387
-0.7%
|
12,94
|
5.008 USD
|
|
2023-06-21 |
2023-06-20 |
V
Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
238
-0.3%
12,94
3.080 USD
|
238
-0.3%
|
12,94
|
3.080 USD
|
|
2023-06-14 |
2023-06-12 |
V
Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
176
-0.2%
13,11
2.307 USD
|
176
-0.2%
|
13,11
|
2.307 USD
|
|
2023-06-14 |
2023-06-12 |
V
Verkauf
|
Trigilio Jeffrey
Chief Financial Officer
Führungsperson
|
319
-0.4%
13,11
4.182 USD
|
319
-0.4%
|
13,11
|
4.182 USD
|
|
2023-06-08 |
2023-06-07 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
100
-0.1%
12,40
1.240 USD
|
100
-0.1%
|
12,40
|
1.240 USD
|
|
2023-06-08 |
2023-06-06 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
11.900
-11.6%
12,31
146.489 USD
|
11.900
-11.6%
|
12,31
|
146.489 USD
|
|
2023-05-24 |
2023-05-23 |
V
Verkauf
|
AHMED NADIM
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
707
-0.6%
9,15
6.469 USD
|
707
-0.6%
|
9,15
|
6.469 USD
|
|
2023-05-19 |
2023-05-18 |
V
Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
239
-0.3%
8,76
2.094 USD
|
239
-0.3%
|
8,76
|
2.094 USD
|
|
2023-05-19 |
2023-05-18 |
V
Verkauf
|
SUMER JACQUELYN L
Chief Legal Officer
Führungsperson
|
291
-0.6%
8,76
2.549 USD
|
291
-0.6%
|
8,76
|
2.549 USD
|
|
2023-05-19 |
2023-05-18 |
V
Verkauf
|
Jones Jeffrey Alan
Chief Medical Officer
Führungsperson
|
394
-0.7%
8,76
3.451 USD
|
394
-0.7%
|
8,76
|
3.451 USD
|
|
2023-05-19 |
2023-05-18 |
V
Verkauf
|
Trigilio Jeffrey
Chief Financial Officer
Führungsperson
|
399
-0.5%
8,76
3.495 USD
|
399
-0.5%
|
8,76
|
3.495 USD
|
|
2023-05-16 |
2023-05-12 |
V
Verkauf
|
Trigilio Jeffrey
Chief Financial Officer
Führungsperson
|
347
-0.4%
8,78
3.047 USD
|
347
-0.4%
|
8,78
|
3.047 USD
|
|
2023-05-16 |
2023-05-12 |
V
Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
193
-0.2%
8,78
1.695 USD
|
193
-0.2%
|
8,78
|
1.695 USD
|
|
2023-04-26 |
2023-04-25 |
V
Verkauf
|
AHMED NADIM
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
716
-0.6%
10,59
7.582 USD
|
716
-0.6%
|
10,59
|
7.582 USD
|
|
2023-04-20 |
2023-04-18 |
V
Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
238
-0.3%
10,71
2.549 USD
|
238
-0.3%
|
10,71
|
2.549 USD
|
|
2023-04-20 |
2023-04-18 |
V
Verkauf
|
Jones Jeffrey Alan
Chief Medical Officer
Führungsperson
|
392
-0.7%
10,71
4.198 USD
|
392
-0.7%
|
10,71
|
4.198 USD
|
|
2023-04-20 |
2023-04-18 |
V
Verkauf
|
Trigilio Jeffrey
Chief Financial Officer
Führungsperson
|
398
-0.5%
10,71
4.263 USD
|
398
-0.5%
|
10,71
|
4.263 USD
|
|
2023-04-20 |
2023-04-18 |
V
Verkauf
|
SUMER JACQUELYN L
Chief Legal Officer
Führungsperson
|
290
-0.6%
10,71
3.106 USD
|
290
-0.6%
|
10,71
|
3.106 USD
|
|
2023-04-14 |
2023-04-12 |
V
Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
176
-0.2%
10,22
1.799 USD
|
176
-0.2%
|
10,22
|
1.799 USD
|
|
2023-04-14 |
2023-04-12 |
V
Verkauf
|
Trigilio Jeffrey
Chief Financial Officer
Führungsperson
|
318
-0.4%
10,22
3.250 USD
|
318
-0.4%
|
10,22
|
3.250 USD
|
|
2023-03-27 |
2023-03-23 |
V
Verkauf
|
AHMED NADIM
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
706
-0.6%
10,51
7.420 USD
|
706
-0.6%
|
10,51
|
7.420 USD
|
|
2023-03-27 |
2023-03-20 |
V
Verkauf
|
SUMER JACQUELYN L
Chief Legal Officer
Führungsperson
|
305
-0.6%
11,32
3.453 USD
|
305
-0.6%
|
11,32
|
3.453 USD
|
|
2023-03-27 |
2023-03-20 |
V
Verkauf
|
Trigilio Jeffrey
Chief Financial Officer
Führungsperson
|
399
-0.5%
11,32
4.517 USD
|
399
-0.5%
|
11,32
|
4.517 USD
|
|
2023-03-27 |
2023-03-20 |
V
Verkauf
|
Jones Jeffrey Alan
Chief Medical Officer
Führungsperson
|
390
-0.7%
11,32
4.415 USD
|
390
-0.7%
|
11,32
|
4.415 USD
|
|
2023-03-27 |
2023-03-20 |
V
Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
238
-0.3%
11,32
2.694 USD
|
238
-0.3%
|
11,32
|
2.694 USD
|
|
2022-11-29 |
2022-11-25 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
See Remarks
Führungsperson
|
4.000
-7.0%
13,30
53.200 USD
|
4.000
-7.0%
|
13,30
|
53.200 USD
|
|
2022-09-29 |
2022-09-27 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
See Remarks
Führungsperson
|
4.000
-7.0%
12,40
49.600 USD
|
4.000
-7.0%
|
12,40
|
49.600 USD
|
|
2022-08-09 |
2022-08-08 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
1.385
-2.5%
15,01
20.789 USD
|
1.385
-2.5%
|
15,01
|
20.789 USD
|
|
2022-08-04 |
2022-08-04 |
V
Verkauf
|
F2 Vision SCS
Large shareholder
|
25.989
-2.0%
14,31
371.788 USD
|
25.989
-2.0%
|
14,31
|
371.788 USD
|
|
2022-08-04 |
2022-08-03 |
V
Verkauf
|
F2 Vision SCS
Large shareholder
|
19.129
-1.5%
14,24
272.334 USD
|
19.129
-1.5%
|
14,24
|
272.334 USD
|
|
2022-08-04 |
2022-08-02 |
V
Verkauf
|
F2 Vision SCS
Large shareholder
|
4.792
-0.4%
14,10
67.554 USD
|
4.792
-0.4%
|
14,10
|
67.554 USD
|
|
2022-07-26 |
2022-07-25 |
GV
Geplanter Verkauf
|
Michaelson Jennifer
Chief Development Officer
Führungsperson
|
8.000
-13.1%
14,51
116.080 USD
|
8.000
-13.1%
|
14,51
|
116.080 USD
|
|
2022-07-21 |
2022-07-19 |
GV
Geplanter Verkauf
|
Savill Corrine
Acting Chief Business Officer
Führungsperson
|
14.958
-9.1%
15,22
227.661 USD
|
14.958
-9.1%
|
15,22
|
227.661 USD
|
|
2022-07-21 |
2022-07-18 |
GV
Geplanter Verkauf
|
Savill Corrine
Acting Chief Business Officer
Führungsperson
|
5.042
-3.0%
15,06
75.933 USD
|
5.042
-3.0%
|
15,06
|
75.933 USD
|
|
2022-07-12 |
2022-07-11 |
GV
Geplanter Verkauf
|
Savill Corrine
Acting Chief Business Officer
Führungsperson
|
200
-0.1%
13,85
2.770 USD
|
200
-0.1%
|
13,85
|
2.770 USD
|
|
2022-07-12 |
2022-07-11 |
GV
Geplanter Verkauf
|
Savill Corrine
Acting Chief Business Officer
Führungsperson
|
39.800
-19.0%
13,33
530.534 USD
|
39.800
-19.0%
|
13,33
|
530.534 USD
|
|
2022-06-23 |
2022-06-23 |
V
Verkauf
|
F2 Bioscience I 2017 Ltd
Large shareholder
|
29.631
-5.2%
13,00
385.310 USD
|
29.631
-5.2%
|
13,00
|
385.310 USD
|
|
2022-06-23 |
2022-06-22 |
V
Verkauf
|
F2 Bioscience I 2017 Ltd
Large shareholder
|
49.953
-8.1%
12,70
634.578 USD
|
49.953
-8.1%
|
12,70
|
634.578 USD
|
|
2022-06-23 |
2022-06-21 |
V
Verkauf
|
F2 Bioscience I 2017 Ltd
Large shareholder
|
22.319
-3.5%
12,77
284.929 USD
|
22.319
-3.5%
|
12,77
|
284.929 USD
|
|
2022-06-07 |
2022-06-06 |
K
Kauf
|
AHMED NADIM
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
8.090
+inf%
12,40
100.316 USD
|
8.090
+inf%
|
12,40
|
100.316 USD
|
|